Quantitation of hemopoietic cell antigens in flow cytometry

European Journal of Histochemistry

Volumn 40, Issue SUPPL.1, 1996, Pages 15-32

  Poncelet, P ^a   George, F ^b   Papa, S ^c   Lanza, F ^d  

^a Biocytex   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITY OF URBINO   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Antigen quantitation; Hematologic malignancies; Quantimetry; Quantitative flow cytometry; Receptor; Standards

Indexed keywords

ANTIGEN;

ANIMAL; BLOOD; BLOOD CELL; BLOOD DISEASE; CHEMISTRY; FLOW CYTOMETRY; HEMATOLOGIC DISEASE; HUMAN; REVIEW; STANDARD;

ANIMALS; ANTIGENS; BLOOD CELLS; FLOW CYTOMETRY; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HUMANS;

EID: 0029679957     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Abrams C.S., Ellison N., Budzynski A.Z., and Shattil S.J.: Direct detection of activated platelets and platelets-derived micro-particles in humans, Blood 75, 128-138, 1990.
2. Altieri D.C., and Edgington T.S.: Identification of effector cell protease receptor-1: a leukocyte-distributed receptor for the serine protease factor Xa, J. Immunol. 145, 246-251, 1990.
3. Amadori A., De Silvestro G., Zamarchi R., Veronese M.L., Mazza M.R., Schiavo G., Panozzo M., De Rossi A., Ometto L., Mous J., Barelli A., Borri A., Salmaso L., and Chieco-Bianchi L.: CD4 epitope masking by gp120/anti-gp120 antibody complexes.A potential mechanism for CD4+ cell function down-regulation in AIDS patients, J. Immunol. 148, 2709-2716, 1992.
4. Ambrosi P., George F., Poncelet P., Besson-Faure I., Chicheportiche C., Luccioni R., and Sampol J.: Effect of recombinant tissue-type plasminogen on ten platelet membrane glycoproteins, Fibrinolysis 6, 193-197, 1992.
5. Anderson D.C., Schmalsteig F.C., Finegold MJ., Hughes BJ., et al.: Abnormalities in polymorphonuclear leucocyte function associated with a heritable deficiency of a high molecular weight surface glyco-proteins (GP138): common relationship to diminished cell adherence, J. Clin. Invest. 74, 536-551, 1984.
6. Anderson D.C., Schmalsteig F.C., Arnaout M.A., Kohl S., Tosi M.F., Dana N., Buffone G.J., Hughes B.J., et al.: The severe and moderate phenotypes of heritable Mac-1,LFA-1 deficiency: their quantitative definition and relation to leucocyte dysfunction and clinical features. J. Inf. Dis. 152, 668-689, 1985.
7. Arnaout M.A., Hakim R.M., Todd III R.F., Dana N., and Colten H.R.: Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis, N. Engl. J. Med. 312, 457-462, 1985.
8. Bator J.M., and Reading C.L.: Measurement of antibody affinity for cell surface antigens using an enzyme-linked immunosorbent assay, J. Immunol. Methods 125, 167-176, 1989.
9. Benè M., Castoldi G.L., Knapp W., Ludwig W.D., Matutes E., Orfao A., and van't Veer M.B. (on behalf of the European Group for the Immunological Characterization of Leukemias -EGIL): Proposals for the immunological classification of acute leukemias. Leukemia 9, 1783-1786, 1995.
10. Besson I., Camoin-Jau L., George F., and Sampol J. (1996): Assessment of the platelet membrane glycoproteins using a standardized quantitative approach by flow cytometry, Brit. J. Haematol., in press, 2nd meeting Eur. Haematol. Ass.(june 1996).
11. Bikoue A., George F., Poncelet P., Mutin M., Janossy G., and Sampol J.: Quantitative analysis of leukocyte membrane antigen expression: normal adult values, Cytometry, 1996 (In press).
12. Bofill M., Gombert W., Borthwick N.J., Akbar A.N, McLogin J.E., Lee C.A., Johnson M.A., Pinching A.J., and Janossy G.: Presence of CD3+CD8+bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph-nodes of HIV1+ patients, Am. J. Pathol. 146, 1542-1555, 1995.
13. Brotherick I., Lennard T.W.J., Wilkinson S.E., Cook S., Angus B., and Shenton B.K.: Flow cytometric method for the measurement of epidermal growth factor receptor and comparison with the radio-ligand binding assay, Cytometry 16, 262-269, 1994.
14. Bunescu A., Lindahl T., Solum N.O., Schulman S., Larsson A., Lundahl J., and Egberg N.: Partial expression of gpIb measured by flow cytometry in two patients with Bernard-Soulier syndrome, Thrombosis Res. 76, 441-450, 1994.
15. Caldwell C.W., Patterson W.P., and Hakami N.: Alterations of HLe-1 (T200) fluorescence intensity on acute lymphoblastic leukemia cells may relate to therapeutic outcome, Leuk. Res. 11, 103-106, 1987.
16. Cantaloube J.F., Piechaczyk M., Calender A., Lenoir G., Minty A., Carriere D., Fisher E., and Poncelet P.: Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells, Eur. J. Immunol. 20, 409-416, 1990.
17. Carayon P., Portier M., Dussossoy D., Bord A., Petitpretre G., Canat X., LeFur G., and Casellas P.: Involvement of peripheral benzodiazepine receptors in the protection of hemopietic cells against oxygen radical damages, Blood, 1996 (in press).
18. Carbonari M., Ciabati M., Cherchi M., Sbarigia D., Pesce A.M., Dell'Anna L., Modice A., and Fiorilli M.: Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel immunocytometric method, Blood 63, 1268-1277, 1994.
19. Carlo Stella C., Cazzola M., De Fabritiis P., De Vincentis A., Gianni A.M., Lanza F., Lauria F., Lemoli R., Tarella C., Zanon P., and Tura S.: CD34-positive cells: biology and clinical relevance (review article). Haematologica 80, 367-387, 1995.
20. Chiron M., Jaffrezou J.P., Carayon P., Bordier C., Roubinet F., Xavier C., Brandely M., and Laurent G.: Induction and increase of HLA-DR expression by immune interferon on ML-3 cell line enhances the anti-HLA-DR immunotoxin activity, Clin. Exp. Immunol. 82, 214-220, 1990.
21. Cohen J.H.M., Autran B., Jouvin M.H., Aubry J.P., Rozenbaum W., Bancherau J., Debré P., Revillard J.P., and Kazatchkine M.: Decreased expression of the receptor for the C3b fragment of complement on erythrocytes of patients with acquired immunodeficiency syndrome, Presse Med. 17, 727-730, 1988.
22. Court W.S., Bozeman J.M., Soong S.J., Saleh M.N., Shaw D.R., and Lobuglio A.F.: Platelet-surface bound IgG in patients with immune and non-immune thrombocytopenia, Blood 69, 278-283, 1987.
23. Coustan-Smith E., Kitanaka A., Ching-Hon Pui, McNinch L., Evans W.E., Raimondi S.C., Behm F.G., Arico M., and Campana D.: Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia, Blood 87, 1140-1148, 1986.
24. Cronstein B.N., Molad Y., Reibman J., Balakhane E., Levin R.I., and Weissman G. (1995): Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils, J. Clin. Invest. 96, 994-1002, 1995.
25. Dawson C.D., Scheppler J.A., Nicholson J.K.A., Handolman R.C.: Enumeration of antigen sites on cells by flow cytometry, Pathobiology 59, 57-61, 1991.
26. Duperray C., Klein B., Durie BGM., Zhang X., Jourdan M., Poncelet P., Favier F., Vincent C., Brochier J., Lenoir J., and Bataille R.: Phenotypic analysis of human myeloma cells, Blood 73, 566-572, 1989.
27. Duperray C., Cantaloube J.F., Boucheix C., Lavabre-Bertrand T., Attal M., Brochier J., Favier F., Bataille R., and Klein B.: The CD24 antigen makes the discrimination of pre-B cells from B cells possible in human bone marrow, J. Immunol. 145, 3678-3683, 1991.
28. Durroux T., Delon P., Carriere D., Carayon P., and Poncelet P.: Quantitative expression of molecules defined by the "New-T" workshop antibodies on various T-cells; modulation of T-lymphocytes upon PHA activation, in: McMichael AJ et al. (eds.), Leucocyte typing III, III, Oxford University Press, 1987, p. 242.
29. Dussossoy D., Carayon P., Feraut D., Belugou S., Combes T., Vidal H., and Casellas P.: Immunological analysis of the cellular localization of the peripheral benzodiazepine receptor, Cytometry, 1996, in press.
30. Dustin M.L., and Springer T.A.: Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells, J. Cell Biol. 107, 321-331, 1988.
31. Dux R., Kindler-Rohrborn G., Lenmartz K., and Rajewsky M.F.: Calibration of fluorescence intensities to quantify antibody binding surface determinants of cell subpopulations by flow cytometry, Cytometry 12, 422-428, 1991.
32. Emendürfer A., Nakamura M., Rothe G., Spiekermann K., Lohmann-Matthes M.L., and Roesler J.: Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions, Cytometry 18, 147-155, 1994.
33. Farabat N., Lens D., Zomas A., Morilla R., Matutes E., and Catowsky D.: Quantitative flow cytometry can distinguish between normal and leukemic B cell precursors, British Journal of Haematology 91, 640-646, 1995.
34. Fay S.P., Posner R.G., Swann W.N., and Sklar L.A.: Real-time analysis of the assembly of ligand,receptor and G protein by quantitative fluorescence flow cytometry, Biochemistry 30, 5066-5075, 1991.
35. Ferrand V., Montero Julian F.A., Chauvet M.M., Hirn M.H., and Bourdeaux M.J.: Quantitative determination of the MDR-related P-glycoprotein, Pgp170,by a rapid flow cytometric technique, Cytometry 23, 120-125, 1996.
36. Gee A., Mansour V.H., and Weiler M.B.: Effects of target antigen density on the efficacy of immunomagnetic cell separation, J. Immunol. Methods 142, 127-136, 1991.
37. George F., Mutin M., Poncelet P., and Sampol J.: Antigenic densities defined by workshop endothelial section monoclonal antibodies, in: Schlossman S.F., Boumsell L., Gilks W., Harlan J.M., Kishimoto T., Morimoto C., Ritz J., Shaw S., Silverstein R., Springer T., Tedder T.F., Todd R.F. (eds.), Leucocyte Typing V, 2, Oxford Univ. Press, 1995, pp. 1798-1801.
38. Gibson N., and Waxman F.J.: Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1,CD35) on human erythrocytes, Clin. Immunol. Immunopathol. 70, 104-113, 1994.
39. Ginsberg M.H., Frelinger A.L., Lam S.C.T., Forsyth J., McMillan R., Plow E.F., and Shattil S.J.: Analysis of platelet aggregation disorders based on flow cytometric analysis of glycoprotein IIb/IIIa with conformation-specific monoclonal antibodies, Blood 76, 2017-2023, 1990.
40. Gougos A., and Letarte M.: Biochemical characterization of the 44G4 antigen from the hoon pre-B leukemic cell line, J. Immunol. 141, 1934-1940, 1988.
41. Heaney M.L., and Golde D.W. (1996): Soluble cytokine receptors, Blood 87, 847-857, 1986.
42. Herbert J.M., Savi P., Laplace C., and Lale A.: IL-4 inhibits LPS-, IL-1B and TNFa-induced expression of tissue factor in endothelial cells and monocytes, FEBS 310, 31-33, 1992.
43. Hermanowski-Vosatka A., Van Strijp J.A.G., Swiggard W.J., and Wright S.D.: Integrin-modulating factor-1: a lipid that alters the function of leukocyte integrins, Cell 68, 341-352, 1992.
44. Horie S., Kizaki K., Ishii H., and Kazama M.: Retinoic acid stimulates expression of thrombomodulin, a cell surface anti-coagulant glycoprotein, on human endothelial cells, Biochem. J. 281, 149-154, 1992.
45. Inoue M., Koga Y., Djordjijevic D., Fukula T., Reddy E.P., Yokoyama M.M., and Sagawa K.: Down-regulation of CD4 molecules by the expression of Nef: a quantitative analysis of CD4 antigens on the cell surfaces, Int. Immunol. 5, 1067-1073, 1993.
46. Islam D., Lindberg A.A., and Christensson B.: Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers a assessed with quantitative multicolor flow cytometry, Cytometry 22, 128-134, 1995.
47. Jackson C.W., and Jennings L.K.: Heterogeneity of fibrinogen receptor expression on platelets activated in normal plasma with ADP: analysis by flow cytometry, British Journal of Haematology 72, 407-414, 1989.
48. Janssen W.E., Lee C., Gross C., and Gee A.P.: Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging, Exp. Hematol. 17, 252-257, 1989.
49. Janossy G., Borthwick N., Lomnitzer R., Medina E., Squire S.B., Phillips A.N., Lipman M., Johnson M.A., Lee C., and Bofill M.: Lymphocyte activation in HIV-1 infection. I Predominant proliferative defects among CD45RO+ cells of the CD4 and CD8 lineages, AIDS 7, 613-624, 1993.
50. Jennings L.K., Ashmun R.A., Wang W.C., and Dockter M.E.: Analysis of human platelet glycoprotein IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry, Blood 68, 173-179, 1986.
51. Joseph M., Capron A., Ameisen J.C., Capron M., Vorng M., Pancre H., Kusnierz J.P., and Auriault C.: the receptor for IgE on blood platelets, Eur. J. Immunol. 16, 306-312, 1986.
52. Kinoshita T., Medof M.E., Silber R., and Nussensweig V.: Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobulinuria, J. Exp. Med. 162, 75-81, 1985.
53. Klimecki W.T., Futscher B.W., Grogan T.M., and Dalton W.S.: Pglycoprotein expression and function in circulating blood cells from normal volunteers, Blood 83, 2451-2458, 1994.
54. Lages B., Shattil J., Bainton D.F., and Weiss H.J.: Decreased contents and surface expression of alpha granule membrane protein GMP140 in one or two types of platelets alpha delta storage pool deficiency, J. Clin. Invest. 87, 919-929, 1991.
55. Lanza F., Rigolin M., Moretti S., Latorraca A., and Castoldi G.L.: Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. Leukemia Lymph. 13,81-85, 1994a.
56. Lanza F., and Castoldi G.: Large scale enrichment of CD34+ cells by percoll density gradients. A CML-based study design. In: Wunder E., Serke S., Sovalat H., and Henon P., eds. Haematopoietic stem cells: the Mulhouse manual. Dayton: Alpha Med Press, pp. 255-270, 1994b.
57. Lanza F., Moretti S., Papa S., Malavasi F., and Castoldi G.L.: Report on the fifth International Workshop on human leukocyte differentiation antigens, Boston, november 3-7, 1993. Haematol 79, 374-386, 1994c.
58. Laurent G., Kuhlein E., Casellas P., Canat X., Carayon P., Poncelet P., Correll S., Rigal F., and Jansen F.K.: Determination of sensitivity of fresh leukemia cells to immunotoxins, Cancer Res. 46, 2289-2294, 1996.
59. Lavabre-Bertrand T., Delon P., Klein B., and Poncelet P.: Quantitative expression of surface antigens recognized by the "new B" monoclonal antibodies on an variety of human B cells, in: McMichael A.J et al. (eds.), Leucocyte Typing III, Oxford University Press, 1987, p. 410.
60. Lavabre-Bertrand T., Duperray C., Brunet C., Poncelet P., Exbrayat C., Bourquard P., Lavabre-Bertrand C., Brochier J., Navarro J., and Janossy G.: Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias, Leukemia 8, 402-408, 1994a.
61. Lavabre-Bertrand T., Exbrayat C., Bourquard P., Lavabre-Bertrand C., Fegueux N., Poncelet P., Roussel T., Taib J., Emberger J.M., and Navarro M.: CD23 antigen density is related to serum gamma globulin level,bone marrow reticulin pattern,and treatment in B chronic lymphocytic leukemia, Leuk & Lymphoma 13, 89-94, 1994b.
62. Lavabre-Bertrand T., Janossy G., Ivory K., Peters R., Secker-Walker L., and Porwit-McDonald A.: Leukemia-associated changes identified by quantitative flow cytometry: I.CD10 expression, Cytometry 18, 209-217, 1994c.
63. Lavabre-Bertrand T., George F., Brunet C., and Sampol J.: Quantitative immune phenotyping: a new dimension for the monitoring of haemopoietic malignancies, Nouv. Rev. Fr. Hematol. 36, 373-382, 1994d.
64. Lavabre-Bertrand T., Janossy G., Exbrayat C., Bourquard P., Duperray C., and Navarro M.: Leukemia-associated changes identified by quantitative flow cytometry.II.CD5 over-expression and monitoring in B-CLL, Leukemia 8, 1557-1563, 1994e.
65. Le Bouteiller P., Mishal Z., Lemonnier F.A., and Kourilsky F.M.: Quantification by flow cytofluorimetry of HLA Class I molecules at the surface of murine cells transformed by cloned HLA genes, J. Immunol. Methods 61, 301-315, 1983.
66. Levacher M., Hulstaert F., Tallet S., Ullery S., Pocidalo J.J., and Bach B.A. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prosnostic value, Clin. Exp. Immunol. 90, 376-382, 1992.
67. Loken M.R., Shah V.O., Hollander Z., and Civin C.I.: Flow cytometric analysis of normal B lymphoid development, Pathol. Immunopathol. Res. 7, 357-370, 1988.
68. Look A.T., Melvin S.L., Brown L.K., Dockter M.E., Roberson P.K., and Murphy S.B.: Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic bone marrow blasts, J. Clin. Invest. 73, 1617-1628, 1984.
69. Macey M.G., and McCarthy D.A.: Quantitation of adhesion molecules and other function-associated antigens on human peripheral blood leucocytes, Cytometry 14, 898-908, 1993.
70. Metzelaar M.J., Sixma J.J., and Nieuwenhuis H.K.: Detection of platelet activation using activation specific monoclonal antibodies, Blood Cells 16, 85-96, 1990.
71. Michelson A.D., and Shattil S.J.: The use of flow cytometry to study platelet activation, in: Watson SP, Authi K (eds.), Platelet function and signal transduction: a practical approach, Oxford Univ. Press, 1995, pp. 39-49.
72. Munn L.L., Koenig G.C., Jain R.K., and Melder R.J.: Kinetics of adhesion molecule expression and spatial organization using targeted sampling fluorometry, BioTechniques 19, 622-631, 1995.
73. Mutin M., Poncelet P., Aubry J.P., George F., and Sampol J.: Quantification of cell-bound monoclonal antibodies with quantitative flow cytometry:alternative standardization approaches, Tissue Antigens 42, 456, 1993.
74. Nicholson J.K.A.: Immunophenotyping specimens from HIV-infected persons: laboratory guidelines from the Centers of Disease Control and Prevention. Cytometry 18, 55-59, 1994.
75. Nicholson-Weller A., March J.P., Rosen C.E., Spicer D.B., and Austen K.F.: Surface membrane expression by human blood leucocytes and platelets of decay-accelerating factor,a regulatory protein of the complement system, Blood 65, 1237-1244, 1995.
76. Oonishi T., and Uyesaka N.: A new standard fluorescence microsphere for quantitative flow cytometry, J. Immunol. Methods 84, 143-154, 1985.
77. Pardi R., Inverardi L., and Bender J.R.: Regulatory mechanisms in leucocyte adhesion. Flexible receptors for sophisticated travellers. Immunology Today 13, 224-230, 1992.
78. Parker R.I., and Gralnick H.R.: Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet von Willebrand factor., Blood 68, 732-736, 1986.
79. Peters R.E., Janossy G., Kamal I., Al-Ismail S., and Mercolino T.: Leukemia-associated changes identified by quantitative flow cytometry.II. B-cell gating in CD37/K/L clonality test, Leukemia 8, 1864-1870, 1994.
80. Petroni K., Shen L., and McGuyre P.: Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by gamma interferon and glucocorticoids, J. Immunol. 140, 3467-3472, 1988.
81. Picker L.J., Singh M.K., Zdravezski Z., Treer J.R., Waldrop S.L., Bergstresser P.R., and Maino V.C.: Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry, Blood 86, 1408-1419, 1995.
82. Pilarski L.M., Turley E.A., Shaw A.R.E., Gallatin W.M., Laderoute M.P., Gillitzer R., Beckman I.G.R., and Zola H.: FMC46,a cell protrusion-associated leucocyte adhesion molecule-1 epitope on human lymphocytes and thymocytes, J. Immunol. 147, 136-141, 1992.
83. Poncelet P., and Carayon P.: Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies, J. Immunol. Methods 85, 65-75, 1985.
84. Poncelet P., Lavabre-Bertrand T., and Carayon P.: Quantitative phenotypes of B chronic lymphocytic leukemia B cells established with monoclonal antibodies from the B cell protocol, in: Reinherz EL, Haynes BF, Nadler LM, Bernstein ID (eds.), Leukocyte Typing II, 2, Springer-Verlag, 1986, pp. 329-343.
85. Poncelet P., Cantaloube J.F., Delon P., Duperray C., and Lavabre-Bertrand T.: Quantitative expression of CD37, the new 40-45 kd cluster, on B and T cells, in: McMichael A.J et al. (eds.), Leucocyte Typing III, Oxford University Press, 1987, pp. 341-345.
86. Poncelet P., Bikoue A., Lavabre T., Poinas G., Parant M., Duperray C., and Sampol J.: Quantitative expression of human lymphocytes membrane antigens: definition of normal densities measured in immuno-cytometry with the QIFI assay, Cytometry 12 Suppl. 5, 418A, 1991a.
87. Poncelet P., Poinas P., Corbeau P., Devaux C., Tubiana N., Tamalet C., Cherman J.C., Kourilsky F., and Sampol J.: Surface CD4 density remains constant on lymphocytes from HIV-infected patients in the progression of disease, Res. Immunol. 142, 1991b.
88. Poncelet P., George F., and Lavabre-Bertrand T.: Immunological detection of membrane-bound antigens and receptors, in: Masseyeff R, Albert W, Staines NA. (eds.), Methods of Immunological Analysis 3, VCH, 1993, pp. 388-417.
89. Poon R., Fernandez-Repollet E., Ottinger J., and Schwartz A.: Characterization of available standards for flow cytometry, FCS Forum. 6, 1-4, 1994.
90. Porwitt-Mc Donald A., Janossy G., Ivory K., Swirsky D., Peters R., Wheatley K., Walker H., Turker A., Goldstone A.H., and Burnett A.: Leukemia-associated changes identified by quantitative flow cytometry. IV . CD34 overexpression in acute myelogeneous leukemia M2 with t(8;21), Blood 87, 1162-1169, 1996.
91. Porwitt-McDonald D., Ivory K., Wilkinson S., Wheatley K., Wong L., and Janossy G.: Bcl-2 protein expression in normal human bone marrow precursors and in AML., Leukemia 9, 1191-1198, 1995.
92. Renkonen R., Paavonen T., Nortamo P., and Gahmberg C.G.: Expression of endothelial adhesion molecules in vivo: increased endothelial ICAM-2 expression in lymphoid malignancies, Am. J. Pathol. 140, 763-767, 1992.
93. Rigolin G.M., Lanza F., and Castoldi G.L.: Multiparameter statistical analysis of quantitative flow cytometry data in acute myeloid leukemias: correlation with FAB classification. Lab. Haematol. 1, 120-127, 1995.
94. Robinson R.A., Worfolk L., and Tracy P.B.: Endotoxin enhances the expression of monocyte prothrombinase activity, Blood 79, 406-416, 1992.
95. Rosa F., and Fellous M.: The effect of gamma-interferon on MHC antigens, Immunology Today 5, 261-262, 1994.
96. Rowley S., Carpenter R., Newbold K.M., et al.: Use of OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer, Eur. J. Surg. Oncol. 17, 370-378, 1991.
97. Satta N., Toti F., Feugeas O., Bohbot A., Dachary-Prigent J., Eschwege V., Hedman H., and Freyssinet J.M.: Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by LPS, J. Immunol. 153, 3245-3255, 1994.
98. Savion N., Isaacs J.D., Gospodarowicz D., and Shuman M.A.: Internalization and degradation of thrombin and up-regulation of thrombin binding sites in corneal endothelial cells, J. Biol. Chem. 256, 4514, 1981.
99. Schwartz A., and Fernandez-Repollet E.: Development of clinical standards for flow cytometry, Ann. N.Y. Acad. Sci. 677, 28-39, 1993.
100. Selvaraj P., Rosse W.F., Silber R., and Springer T.A.: The major Fc receptor in blood has a phosphatidyl-inositol anchor and is deficient in paroxysmal nocturnal hemoglobulinuria, Nature 333, 565-567, 1988.
101. Shah V.O., Civin C.I., and Loken M.R.: Flow cytometric analysis of human bone marrow.IV. Differential quantitative expression of T200 common leucocyte antigen during normal hemopoiesis, J. Immunol. 140, 1861-1867, 1988.
102. Shapiro H.M., and Shapiro H.M.: Putting the -metry into immunofluorescence flow cytometry, Cytometry 12 Suppl. 5, 70, 1991.
103. Shattil S.J., Cunningham M., and Hoxie J.A.: Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry, Blood 70, 307-315, 1987.
104. Sims J.E., March C.J., Cosman D., Widmer M.B., McDonald H.R., McMahan C.J., Grubin C.E., Wignall J.M., Jackson J.L., Call S.M., Friend D., Alpert A.R., Gillis S., Urdal D.L., and Dower S.K.: cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily, Science 241, 585-589, 1988.
105. Smythe J., Gardner B., and Anstee D.J.: Quantitation of the number of molecules of glycophorins C and D on normal red blood cells using radioiodinated Fab fragments of monoclonal antibodies, Blood 83, 1668-1672, 1994.
106. Stelzer G.: Analysis of leukocyte function by flow cytometric techniques, Cytometry 9 Suppl. 3, 52-59, 1988.
107. Stewart C.C.: Clinical applications of flow cytometry. Immunologic methods for measuring cell membrane and cytoplasmic antigens, Cancer 69 Supp, 1543-1552, 1992.
108. Stockinger H., Valent P., Majdic O., Bettelheim P., and Knapp W.: Human blood basophils synthesize interleukin-2 binding sites, Blood 75, 1820-1826, 1990.
109. Talbot D.: A rapid, objective method for the detection of lympho-cytotoxic antibodies using flow cytometry. J. Immunol. Methods 99, 137-140, 1987.
110. Thibault G., and Bardos P.: Compared TcR and CD3-epsilon expression on alpha-beta and gamma-delta T cells. Evidence for the association of two TcR heterodimers with three CD3-E chains in the TcR/CD3 complex, J. Immunol. 154, 3814-3820, 1995.
111. Thieblemont N., Weiss L., Sadeghi H.M., Estcourt C., and Haeffner-Cavaillon N.: CD14 low CD16 high: a cytokine-producing monocyte subset which expands during human immunodeficiency vitus infection, Eur. J. Immunol. 25, 3418-3424, 1995.
112. Titus J.A., Sharrow S.O., Conolly J.M., and Segal D.M.: Fc(IgG) receptor distributions in homogeneous and heterogeneous cell populations by flow microfluorometry, Proc. Natl. Acad. Sci. USA 78, 519-523, 1981.
113. Tracy P.B., Eide L.L., and Mann K.G.: Human prothrombinase complex assembly and function on isolated peripheral blood cell populations, J. Biol. Chem. 260, 2119-2124, 1985.
114. Tran-Paterson R., Boileau G., Giguere V., and Letarte M. (1990): Comparative levels of Calla/Neutral endopeptidase on normal granulocytes,leukemic cells and transfected Cos-1 cells, Blood 76, 775-782, 1990.
115. Van Acker K.L., Van Hove L.M., and Boogaerts M.A.: Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies, Cytometry 14, 736-746, 1993.
116. Von dem Borne A.E.G.K., and Modderman P.: Cluster report: CD9, in: Knapp W et al. (eds.), Leucocyte Typing IV, 1, Oxford Univ. Press, 1989, p. 989.
117. Werfel T., Witter W., and Gütze O.: CD11b and CD11c antigens are rapidly increased on human natural killer cells upon activation, J. Immunol. 142, 2423-2427, 1991.
118. Yokoyama S., Staunton D., Fisher R., Amiot M., Fortin J.J., and Thorley-Lawson D.A.: Expression of the Blast-1 activation adhesion molecule and its identifiaction as CD48. J. Immunol. 146, 2192-2200, 1991.
119. Youinou P., Meroni P.L., Khamasta M.A., and Shoenfeld Y.: A need for standardization of the anti-endothelial-cell antibody test, Immunology Today 16, 363-364, 1995.
120. Zhao X., McBride B., Trouten-Radford L., and Lissemore K.: Decreased insulin-like growth-factor 1 (IgF1) receptor sites on circulating mononuclear cells from cows with persistent lymphocytosis, J. Receptor Res. 13, 1161-1172, 1993.